Similar articles for PMID: 34475244

Year	Number of Results
2011	3
2013	1
2014	1
2015	2
2016	4
2017	6
2018	15
2019	16
2020	21
2021	23
2024	0

1

Progress in Prostate Cancer Theranostics.

Wahl RL. Wahl RL. J Nucl Med. 2021 Sep 1;62(9):11N. J Nucl Med. 2021. PMID: 34475244 Free article. No abstract available.

2

Changing the Goal Posts: Prostate-specific Membrane Antigen Targeted Theranostics in Prostate Cancer.

Emmett L. Emmett L. Semin Oncol Nurs. 2020 Aug;36(4):151052. doi: 10.1016/j.soncn.2020.151052. Epub 2020 Jul 13. Semin Oncol Nurs. 2020. PMID: 32674976 Review.

3

PSMA Theranostics: Current Landscape and Future Outlook.

Zhang H, Koumna S, Pouliot F, Beauregard JM, Kolinsky M. Zhang H, et al. Cancers (Basel). 2021 Aug 10;13(16):4023. doi: 10.3390/cancers13164023. Cancers (Basel). 2021. PMID: 34439177 Free PMC article. Review.

4

Theranostics in Metastatic Castrate Resistant Prostate Cancer.

Vorster M, Sathekge MM. Vorster M, et al. In: Bott SRJ, Ng KL, editors. Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 May 27. Chapter 6. In: Bott SRJ, Ng KL, editors. Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 May 27. Chapter 6. PMID: 34181373 Free Books & Documents. Review.

5

Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer.

Mukherjee A, Paul M, Mukherjee S. Mukherjee A, et al. Cancers (Basel). 2019 Apr 29;11(5):597. doi: 10.3390/cancers11050597. Cancers (Basel). 2019. PMID: 31035440 Free PMC article. Review.

6

Dawn of Theranostics in Myanmar (Dream, Reality, and Constraint).

Myint K, Thein TM, Phyu TK, Maung W. Myint K, et al. Nucl Med Mol Imaging. 2019 Feb;53(1):42-46. doi: 10.1007/s13139-018-00569-4. Epub 2019 Jan 11. Nucl Med Mol Imaging. 2019. PMID: 30828400 Free PMC article.

7

Current status of theranostics in prostate cancer.

Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C. Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):471-495. doi: 10.1007/s00259-017-3882-2. Epub 2017 Dec 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29282518 Free PMC article. Review.

8

Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.

Farolfi A, Fendler W, Iravani A, Haberkorn U, Hicks R, Herrmann K, Walz J, Fanti S. Farolfi A, et al. Eur Urol Oncol. 2019 Mar;2(2):152-162. doi: 10.1016/j.euo.2019.01.001. Epub 2019 Jan 31. Eur Urol Oncol. 2019. PMID: 31017091 Review.

9

The application of theranostics in different stages of prostate cancer.

Alghazo O, Eapen R, Koschel S, Cumberbatch M, Buteau J, Loh R, Lawrentschuk N, Murphy DG. Alghazo O, et al. Future Oncol. 2021 Sep;17(27):3637-3644. doi: 10.2217/fon-2020-1209. Epub 2021 Jul 6. Future Oncol. 2021. PMID: 34227404

10

Application of Theranostics in Oncology.

Lymperopoulos G, Lymperopoulos P, Alikari V, Dafogianni C, Zyga S, Margari N. Lymperopoulos G, et al. Adv Exp Med Biol. 2017;989:119-128. doi: 10.1007/978-3-319-57348-9_10. Adv Exp Med Biol. 2017. PMID: 28971421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year